Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia

NCT00138736 is registered in ClinicalTrials.gov with Prothya Biosolutions as lead sponsor.

NCT NCT00138736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00138736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Lead sponsor
Prothya Biosolutions
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
October 31, 2006
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mbl-deficient, neutropenia